<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04226001</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL19_0022</org_study_id>
    <secondary_id>2019-A00074-53</secondary_id>
    <nct_id>NCT04226001</nct_id>
  </id_info>
  <brief_title>Impact of a Carrier (Infection, Colonization) of Highly Bacteria Resistance on the Patient's Quality of Life Hospital Environment</brief_title>
  <acronym>QALYBHRe</acronym>
  <official_title>Impact of a Carrier (Infection, Colonization) of Highly Bacteria Resistance on the Patient's</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The quality of life of carriers detected infected or colonized by emerging highly resistant
      bacteria (BHRe) following the implementation of specific hygiene measures during the
      discovery of the microorganism has been little studied. To date, there have been no studies
      to determine the quality of life (QoL) in France of patients with hospitalized HBHRD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">February 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Impact of the implementation of Complementary Hygiene Precautions following a carrier of emerging highly resistant bacteria on the quality of life of hospitalized patients</measure>
    <time_frame>12 months</time_frame>
    <description>Measurement of the decrease in utility corresponding to the deterioration of the QOL of patients since the implementation of the Additional Hygiene Precautions (PCH) following the discovery of their emerging highly resistant bacteria (BHRe).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Bacterial Infections</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <description>Patients screened for carriers infected or colonized by emerging highly resistant bacteria.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality of life questionnaire</intervention_name>
    <description>Quality of life questionnaire</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients infected or colonized by emerging highly resistant bacteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt; 18 years old

          -  Have a positive BHRe screening during the hospital stay and / or have a positive BHRe
             clinical sample during the hospital stay

          -  Conscious patients

          -  All types of stays in the hospital sector

          -  All pathologies

        Exclusion Criteria:

          -  Known patients with BHRe before hospitalization

          -  PCH immediately upon admission (history of hospitalization abroad, patients contacted
             during a previous hospitalization)

          -  Cognitive problem

          -  Patients not proficient in French (requiring an interpreter)

          -  Patients under guardianship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David NARBEY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David NARBEY, MD</last_name>
    <phone>04 78 86 49 31</phone>
    <phone_ext>+33</phone_ext>
    <email>david.narbey@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Lyon Sud</name>
      <address>
        <city>Pierre-Bénite</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David NARBEY, MD</last_name>
      <phone>04 78 86 49 31</phone>
      <email>david.narbey@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>David NARBEY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 9, 2020</study_first_submitted>
  <study_first_submitted_qc>January 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2020</study_first_posted>
  <last_update_submitted>January 9, 2020</last_update_submitted>
  <last_update_submitted_qc>January 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

